Strategic Investment Advisors MI Boosts Stock Position in STERIS plc (NYSE:STE)


Share on StockTwits

Strategic Investment Advisors MI increased its stake in STERIS plc (NYSE:STE) by 5.8% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,874 shares of the medical equipment provider’s stock after buying an additional 102 shares during the period. Strategic Investment Advisors MI’s holdings in STERIS were worth $355,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of STE. First Horizon Advisors Inc. raised its stake in shares of STERIS by 11.1% in the third quarter. First Horizon Advisors Inc. now owns 581 shares of the medical equipment provider’s stock worth $102,000 after purchasing an additional 58 shares during the last quarter. Intrust Bank NA raised its position in STERIS by 1.8% in the 3rd quarter. Intrust Bank NA now owns 3,316 shares of the medical equipment provider’s stock worth $584,000 after buying an additional 59 shares during the last quarter. CX Institutional raised its position in STERIS by 72.7% in the 3rd quarter. CX Institutional now owns 209 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 88 shares during the last quarter. Krueger & Catalano Capital Partners LLC raised its position in STERIS by 1.1% in the 3rd quarter. Krueger & Catalano Capital Partners LLC now owns 8,909 shares of the medical equipment provider’s stock worth $1,557,000 after buying an additional 95 shares during the last quarter. Finally, NBW Capital LLC raised its position in STERIS by 0.3% in the 3rd quarter. NBW Capital LLC now owns 31,956 shares of the medical equipment provider’s stock worth $5,630,000 after buying an additional 97 shares during the last quarter. Institutional investors own 89.97% of the company’s stock.

Shares of STE opened at $194.10 on Thursday. The stock has a market capitalization of $16.56 billion, a price-to-earnings ratio of 40.35 and a beta of 0.66. STERIS plc has a 1 year low of $105.69 and a 1 year high of $203.90. The business’s 50 day simple moving average is $190.05 and its 200-day simple moving average is $174.27. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.29 and a quick ratio of 1.71.

STERIS (NYSE:STE) last issued its quarterly earnings data on Monday, November 2nd. The medical equipment provider reported $1.48 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.21. STERIS had a return on equity of 16.24% and a net margin of 13.69%. The business had revenue of $756.13 million for the quarter, compared to analysts’ expectations of $719.54 million. During the same period in the prior year, the firm earned $1.32 EPS. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. On average, sell-side analysts expect that STERIS plc will post 5.64 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, December 18th. Investors of record on Tuesday, November 24th were issued a dividend of $0.40 per share. The ex-dividend date was Monday, November 23rd. This represents a $1.60 annualized dividend and a yield of 0.82%. STERIS’s payout ratio is presently 28.37%.

STE has been the subject of a number of recent analyst reports. Stephens boosted their target price on STERIS from $170.00 to $200.00 in a research report on Wednesday, October 7th. JMP Securities boosted their target price on STERIS from $180.00 to $200.00 in a research report on Thursday, October 8th. Robert W. Baird boosted their price target on STERIS from $200.00 to $230.00 and gave the company an “outperform” rating in a research note on Wednesday. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research note on Friday, November 20th. Finally, BidaskClub raised STERIS from a “hold” rating to a “buy” rating in a report on Tuesday, January 5th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $197.00.

In other news, CAO Karen L. Burton sold 4,602 shares of the company’s stock in a transaction that occurred on Thursday, November 5th. The stock was sold at an average price of $179.42, for a total value of $825,690.84. Following the completion of the sale, the chief accounting officer now directly owns 10,746 shares in the company, valued at $1,928,047.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, November 6th. The shares were sold at an average price of $181.39, for a total value of $1,813,900.00. Following the completion of the sale, the chief executive officer now owns 71,405 shares of the company’s stock, valued at $12,952,152.95. The disclosure for this sale can be found here. Insiders have sold a total of 19,162 shares of company stock worth $3,503,903 in the last 90 days. 1.20% of the stock is currently owned by insiders.

STERIS Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Further Reading: Intrinsic Value

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.